title: Reply: To PMID 24679845.
authors.affiliation: Division of Rheumatology, Allergy and Clinical Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass. Electronic address: AALONG@mgh.harvard.edu.
authors.forename: Aidan
authors.initials: A
authors.lastname: Long
authors.affiliation: RTI Health Solutions, Research Triangle Park, NC.
authors.forename: Kenneth
authors.initials: K
authors.lastname: Rothman
authors.affiliation: Genentech, South San Francisco, Calif.
authors.forename: Hubert
authors.initials: H
authors.lastname: Chen
authors.affiliation: Genentech, South San Francisco, Calif.
authors.forename: Gillis
authors.initials: G
authors.lastname: Carrigan
authors.affiliation: Children's Hospital Colorado and University of Colorado School of Medicine, Denver, Colo.
authors.forename: Stanley
authors.initials: S
authors.lastname: Szefler
mesh_terms: D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy* / Q000453:epidemiology*; D005260:Female; D006801:Humans; D008297:Male; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000453:epidemiology*
chemical_list: D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized